Overexpression of angiotensin II type 1 receptor in breast cancer cells induces epithelial-mesenchymal transition and promotes tumor growth and angiogenesis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Oh, Eunhye | - |
dc.contributor.author | Kim, Ji Young | - |
dc.contributor.author | Cho, Youngkwan | - |
dc.contributor.author | An, Hyunsook | - |
dc.contributor.author | Lee, Nahyun | - |
dc.contributor.author | Jo, Hunho | - |
dc.contributor.author | Ban, Changill | - |
dc.contributor.author | Seo, Jae Hong | - |
dc.date.accessioned | 2021-09-03T23:09:59Z | - |
dc.date.available | 2021-09-03T23:09:59Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2016-06 | - |
dc.identifier.issn | 0167-4889 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/88403 | - |
dc.description.abstract | The angiotensin II type I receptor (AGTR1) has been implicated in diverse aspects of human disease, from the regulation of blood pressure and cardiovascular homeostasis to cancer progression. We sought to investigate the role of AGTR1 in cell proliferation, epithelial-mesenchymal transition (EMT), migration, invasion, angiogenesis and tumor growth in the breast cancer cell line MCF7. Stable overexpression of AGTR1 was associated with accelerated cell proliferation, concomitant with increased expression of survival factors including poly(ADP-ribose) polymerase (PARP) and X-linked inhibitor of apoptosis (XIAP), as well as extracellular signal-regulated kinase (ERK) activation. AGTR1-overexpressing MCF7 cells were more aggressive than their parent line, with significantly increased activity in migration and invasion assays. These observations were associated with changes in EMT markers, including reduced E-cadherin expression and increased p-Smad3, Smad4 and Snail levels. Treatment with the AGTR1 antagonist losartan attenuated these effects. AGTR1 overexpression also accelerated tumor growth and increased Ki-67 expression in a xenograft model. This was associated with increased tumor angiogenesis, as evidenced by a significant increase in microvessels in the intratumoral and peritumoral areas, and enhanced tumor invasion, with the latter response associated with increased EMT marker expression and matrix metallopeptidase 9 (MMP-9) upregulation. In vivo administration of losartan significantly reduced both tumor growth and angiogenesis. Our findings suggest that AGTR1 plays a significant role in tumor aggressiveness, and its inhibition may have therapeutic implications. (C) 2016 Elsevier B.V. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER | - |
dc.subject | E-CADHERIN EXPRESSION | - |
dc.subject | PI3K PATHWAY ACTIVATION | - |
dc.subject | TGF-BETA | - |
dc.subject | MICROVESSEL DENSITY | - |
dc.subject | NEGATIVE BREAST | - |
dc.subject | DOWN-REGULATION | - |
dc.subject | POOR-PROGNOSIS | - |
dc.subject | GASTRIC-CANCER | - |
dc.subject | SMAD PROTEINS | - |
dc.subject | MAP KINASE | - |
dc.title | Overexpression of angiotensin II type 1 receptor in breast cancer cells induces epithelial-mesenchymal transition and promotes tumor growth and angiogenesis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Ji Young | - |
dc.contributor.affiliatedAuthor | Seo, Jae Hong | - |
dc.identifier.doi | 10.1016/j.bbamcr.2016.03.010 | - |
dc.identifier.scopusid | 2-s2.0-84960930905 | - |
dc.identifier.wosid | 000375885800001 | - |
dc.identifier.bibliographicCitation | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, v.1863, no.6, pp.1071 - 1081 | - |
dc.relation.isPartOf | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | - |
dc.citation.title | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | - |
dc.citation.volume | 1863 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 1071 | - |
dc.citation.endPage | 1081 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | E-CADHERIN EXPRESSION | - |
dc.subject.keywordPlus | PI3K PATHWAY ACTIVATION | - |
dc.subject.keywordPlus | TGF-BETA | - |
dc.subject.keywordPlus | MICROVESSEL DENSITY | - |
dc.subject.keywordPlus | NEGATIVE BREAST | - |
dc.subject.keywordPlus | DOWN-REGULATION | - |
dc.subject.keywordPlus | POOR-PROGNOSIS | - |
dc.subject.keywordPlus | GASTRIC-CANCER | - |
dc.subject.keywordPlus | SMAD PROTEINS | - |
dc.subject.keywordPlus | MAP KINASE | - |
dc.subject.keywordAuthor | Breast cancer | - |
dc.subject.keywordAuthor | AGTR1 | - |
dc.subject.keywordAuthor | EMT | - |
dc.subject.keywordAuthor | Losartan | - |
dc.subject.keywordAuthor | Smad4 | - |
dc.subject.keywordAuthor | Angiogenesis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.